Literature DB >> 16044329

Specific antibody production in herpes keratitis: intraocular inflammation and corneal neovascularisation as predicting factors.

Pierre-Yves Robert1, Anja Liekfeld, Sylvia Metzner, Sylvie Ranger-Rogez, Jean-Paul Adenis, François Denis, Christian Hartmann, Uwe Pleyer.   

Abstract

PURPOSE: The purpose of the study is to investigate whether analysis of specific antibody synthesis can aid the diagnosis of herpes keratitis.
METHODS: Aqueous humor was collected from 39 patients with presumed recurrent herpes keratitis, including 23 consulting for keratitis and 16 patients scheduled for penetrating keratoplasty. Local antibody production was ascertained by analysis of paired aqueous humor/serum samples, using a modified micro-ELISA technique.
RESULTS: Local production of antibodies was found in 32 patients (82%): anti-herpes simplex virus (HSV) antibodies in 26 (67%) and anti-varicella zoster virus (VZV) antibodies in 11 (28%). Twenty of 23 patients with active keratitis (87%), and 12 of 16 undergoing keratoplasty (75%), tested positive. Five patients had local production of both anti-HSV and anti-VZV antibodies, whereas seven patients tested negative. Local antibody production was significantly associated with intraocular inflammation (P<0.05), corneal neovascularisation (P<0.05), and positive response to anti-viral treatment (P<0.05). No complications were encountered in sampling aqueous humor.
CONCLUSIONS: Assessment of local anti-HSV and -VZV antibody production is a safe and reliable diagnostic procedure for recurrent herpes keratitis. It might be particularly helpful in patients presenting with intraocular inflammation and neovascularisation since it discriminates between herpes and non-herpes pathologies and may therefore be useful for preventive and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044329     DOI: 10.1007/s00417-005-0014-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  29 in total

1.  Antibodies to herpes simplex virus type I in intraocular fluids of patients with acute retinal necrosis.

Authors:  N Sarkies; Z Gregor; T Forsey; S Darougar
Journal:  Br J Ophthalmol       Date:  1986-02       Impact factor: 4.638

2.  Etiology of immune stromal (interstitial) keratitis.

Authors:  G S Schwartz; A R Harrison; E J Holland
Journal:  Cornea       Date:  1998-05       Impact factor: 2.651

3.  [Analysis of the aqueous humor in keratoplasty patients with keratitis. Initial results].

Authors:  A Liekfeld; C Jaeckel; U Pleyer; P Y Robert; C Hartmann
Journal:  Ophthalmologe       Date:  2001-05       Impact factor: 1.059

4.  International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease.

Authors:  E Bloch-Michel; R B Nussenblatt
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

5.  Interpretation of intraocular and serum antibody levels in necrotizing retinitis.

Authors:  J L Davis; W Feuer; W W Culbertson; S C Pflugfelder
Journal:  Retina       Date:  1995       Impact factor: 4.256

6.  [Filtration and local synthesis of proteins in human aqueous humour and cerebrospinal fluid].

Authors:  C Hartmann; K Felgenhauer; C Hanssen
Journal:  Fortschr Ophthalmol       Date:  1983

7.  Superiority of antibody versus delayed hypersensitivity in clearance of HSV-1 from eye.

Authors:  R N Lausch; C Monteiro; W R Kleinschrodt; J E Oakes
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-03       Impact factor: 4.799

8.  Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons.

Authors:  B E van Gelderen; A Van der Lelij; W F Treffers; R van der Gaag
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

9.  Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group.

Authors: 
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

10.  Evidence for herpes simplex viral latency in the human cornea.

Authors:  S B Kaye; C Lynas; A Patterson; J M Risk; K McCarthy; C A Hart
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

View more
  6 in total

1.  Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness.

Authors:  Defne Amado; Federico Mingozzi; Daniel Hui; Jeannette L Bennicelli; Zhangyong Wei; Yifeng Chen; Erin Bote; Rebecca L Grant; Jeffrey A Golden; Kristina Narfstrom; Nasreen A Syed; Stephen E Orlin; Katherine A High; Albert M Maguire; Jean Bennett
Journal:  Sci Transl Med       Date:  2010-03-03       Impact factor: 17.956

Review 2.  [Bacterial keratitis. Current diagnostic aspects].

Authors:  U Pleyer; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

3.  Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs' heterochromic cyclitis.

Authors:  Peter C Ruokonen; Sylvia Metzner; Aylin Ucer; Necip Torun; Jörg Hofmann; Uwe Pleyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04       Impact factor: 3.117

Review 4.  [Intraocular pressure related to uveitis].

Authors:  U Pleyer; P Ruokonen; C Heinz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

5.  Regulation of blood vessel versus lymphatic vessel growth in the cornea.

Authors:  Eui-Sang Chung; Daniel R Saban; Sunil K Chauhan; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-21       Impact factor: 4.799

6.  Targeting herpetic keratitis by gene therapy.

Authors:  Hossein Mostafa Elbadawy; Marine Gailledrat; Carole Desseaux; Diego Ponzin; Stefano Ferrari
Journal:  J Ophthalmol       Date:  2012-12-26       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.